Peripheral Neuropathy Trial, Recruiting NCT05884125 Sponsor: Checkpoint Surgical Inc. Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT05884125
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a nerve injury in the arm, anywhere from the shoulder nerve network (brachial plexus) down to the wrist.
  • People whose injury affects either mixed nerves (which carry both movement and sensation signals) or motor nerves (which control movement).
  • People who have been assessed as needing surgery to repair the injured nerve.
  • People whose planned surgery involves one of these techniques: nerve transfer, direct nerve repair, or nerve grafting.
  • People between 18 and 80 years of age.
  • People who have signed and dated a consent form agreeing to take part.

Who may not be able to join:

  • People who have a serious health condition, such as an irregular heartbeat or heart failure, that makes surgery unsafe.
  • People whose nerve repair would require a graft longer than 6 centimetres.
  • People whose nerve repair surgery would take place more than 12 months after the original injury occurred.
  • People younger than 18 or older than 80 years of age.
  • People for whom the required surgery is otherwise not suitable, including those with language barriers, cognitive or mental health barriers, an inability to give informed consent, or who are pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amy M Moore, MD, Ohio State University

Phone: 216-370-9107

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Checkpoint Surgical Inc.
Registry
ClinicalTrials.gov
Start date
12 June 2023
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Motor Recovery assessed using the Medical Research Council (MRC) motor grading

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov